Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
Lei Gao, Yong Hu, Yahui Tian, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 243
Patient‐derived xenograft model in cancer: establishment and applications
Ao Gu, Jiatong Li, Mengyao Li, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 6
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
Bowei Liu, Zhigang Peng, Hao Zhang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 678-696
Closed Access | Times Cited: 44
METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
Zihao Dai, Wanjie Zhu, Yingdong Hou, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3225-3242
Open Access | Times Cited: 24
GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation
Yuxi Yang, Shuangshuang Song, Shujing Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 9
Cryoablation-induced modulation of Treg cells and the TGF-β pathway in lung adenocarcinoma: implications for increased antitumor immunity
Shicheng Lin, Dianna Liu, Tianyu Liang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Patient-derived xenografts (PDXs) as model systems for human cancer
Federica Invrea, Roberta Rovito, Erica Torchiaro, et al.
Current Opinion in Biotechnology (2020) Vol. 63, pp. 151-156
Open Access | Times Cited: 59
Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer
Dhananjay Huilgol, Prabhadevi Venkataramani, Saikat Nandi, et al.
Genes (2019) Vol. 10, Iss. 10, pp. 794-794
Open Access | Times Cited: 58
The Roles of Secreted Wnt Ligands in Cancer
Johannes Werner, Kim E. Boonekamp, Tianzuo Zhan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5349-5349
Open Access | Times Cited: 20
WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice
Wanting Xue, Lihong Cai, Su Li, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Oncogenic SIRT7 inhibits GATA4 transcriptional activity and activates the Wnt signaling pathway in ovarian cancer
Guocheng Li, Wenwen Xu, Xuelin Li, et al.
Gynecologic Oncology (2023) Vol. 171, pp. 39-48
Closed Access | Times Cited: 14
Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine
Xiaoliang Huang, Zuyuan Chen, Xiaoyun Xiang, et al.
The EPMA Journal (2022) Vol. 13, Iss. 4, pp. 671-697
Closed Access | Times Cited: 22
Fluorometric immunoassay for the simultaneous determination of the tumor markers carcinoembryonic antigen and cytokeratin 19 fragment using two kinds of CdSe/ZnS quantum dot nanobeads and magnetic beads
Lihua Ding, Xiao Chen, Leiliang He, et al.
Microchimica Acta (2020) Vol. 187, Iss. 3
Closed Access | Times Cited: 28
Genetic variation in patent foramen ovale: a case-control genome-wide association study
Bosi Dong, Yajiao Li, Fandi Ai, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Structural and mechanistic diversity in p53-mediated regulation of organismal longevity across taxonomical orders
Romani Osbourne, Kelly M. Thayer
PLoS Computational Biology (2025) Vol. 21, Iss. 5, pp. e1012382-e1012382
Open Access
A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients
Yingli Zhang, Xiaoliang Shi, Jiejie Zhang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity
Shuyu Guo, Jiawen Gu, Junqing Ma, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8379-8395
Open Access | Times Cited: 22
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
Andrea Bacci, Massimiliano Runfola, Simona Sestito, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 367-367
Open Access | Times Cited: 21
TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway
Yahui Tian, Shaowei Xin, Zitong Wan, et al.
Translational Oncology (2024) Vol. 45, pp. 101978-101978
Open Access | Times Cited: 3
The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer
Wenqian Yu, Xiaona Lin, Shuai Leng, et al.
Translational Oncology (2024) Vol. 46, pp. 102014-102014
Open Access | Times Cited: 3
Identifying the key hub genes linked with lung squamous cell carcinoma by examining the differentially expressed and survival genes
Anushka Pravin Chawhan, Norine Dsouza
Molecular Genetics and Genomics (2024) Vol. 299, Iss. 1
Closed Access | Times Cited: 3
Inactivation of tumor suppressor gene Clusterin leads to hyperactivation of TAK1-NF-κB signaling axis in lung cancer cells and denotes a therapeutic opportunity
Zhipeng Chen, Zhenzhen Fan, Xiaowei Dou, et al.
Theranostics (2020) Vol. 10, Iss. 25, pp. 11520-11534
Open Access | Times Cited: 22
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells
Rupesh S. Patel, Rodrigo Romero, Emma V. Watson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function
Jinxia Liang, Feng Lu, Bo Li, et al.
Cell Cycle (2019) Vol. 18, Iss. 23, pp. 3300-3312
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top